Hydroxyurea improves nitric oxide bioavailability in humanized sickle cell mice

Despite advancements in disease management, sickle cell nephropathy, a major contributor to mortality and morbidity in patients, has limited therapeutic options. Previous studies indicate hydroxyurea, a commonly prescribed therapy for sickle cell disease (SCD), can reduce renal injury in SCD but the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Am J Physiol Regul Integr Comp Physiol
Autori principali: Taylor, Crystal M., Kasztan, Malgorzata, Sedaka, Randee, Molina, Patrick A., Dunaway, Luke S., Pollock, Jennifer S., Pollock, David M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Physiological Society 2021
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8163606/
https://ncbi.nlm.nih.gov/pubmed/33624556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpregu.00205.2020
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi